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Abstract: Background: Pituitary apoplexy is a clinical syndrome secondary to rapid 
expansion of the content of the sella and extension to suprasellar region, cavernous sinus, 
sphenoid sinus secondary to a bleeding, ischemic or mixed episode taking place in a 
pituitary adenoma. This episode will determine a significant compression of the optic 
nerves, optic chiasm, cavernous sinus and hypothalamus, which translates clinically 
most often by headache, visual disturbances, deceased level of consciousness and 
ophthalmoplegia. Material and methods: This paper presents a retrospective study over 
a period of five years, from January 2009 to December 2013 and includes 98 patients 
diagnosed with pituitary apoplexy and treated in the Third Department of Neurosurgery, 
Emergency Clinical Hospital Bagdasar-Arseni. Of the 98 patients, 62 were females (63.3 
%) and 36 were males (36.7 %) with a ratio of female to male of 1.7:1. The patients were 
aged between 17 and 75 years old, average age being approximately 50 years. Follow-up 
period ranged from 2 months to 5 years. The main symptomsat presentation was sudden, 
intense headache, this symptom was encountered in 90 patients (91.83%), vomiting 
showed by 76 patients (77.55%), decreased visual acuity observed in 57 patients (58.16%), 
visual field deficits in 74 patients (75.51%), cranial nerves palsy (III, IV, VI) observed in 
14 patients (14.28 %). Conclusions: Pituitary apoplexy is a disease that can endanger 
patients' lives. The clinical presentation may vary from minor symptoms to major 
neurological deficits and even death so early diagnosis and treatment are vital. 
Key words: apoplexy, pituitary adenoma. 
 
Background and epidemiological 
considerations 
Pituitary apoplexy is one of the major 
neurosurgical emergencies especially due to 
compression of the optic nerves and chiasm 
and associated hormonal imbalance. In this 
paper, we present a retrospective study 
conducted over a period of 5 years which 
includes patients diagnosed with pituitary 
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apoplexy and treated in the Third Department 
of Neurosurgery from Emergency Clinical 
Hospital Bagdasar-Arseni, Bucharest. 
In this paper, we propose to draw attention 
to the importance of early diagnosis and 
treatment of these patients given the 
sometimes disastrous consequences of this 
condition on visual and endocrinefunction. 
Also, we will make an analysis of the literature 
for a better understanding of this 
neurosurgical pathology. 
Pituitary apoplexy is a clinical syndrome 
secondary to rapid expansion of the content of 
the sella and extension to suprasellar region, 
cavernous sinus, sphenoid sinus secondary to 
a bleeding episode, ischemic or mixed episode 
(ischemic and hemorrhagic) taking place in a 
pituitary adenoma. The hemorrhagic, 
ischemic or mixed episode will determine a 
significant compression of the optic nerves, 
optic chiasm, cavernous sinus and 
hypothalamus, which translates clinically most 
often by headache, visual disturbances, 
deceased level of consciousness and 
ophthalmoplegia. (1) 
The first subtemporal decompression for a 
pituitary adenoma was practiced by Paul, a 
British neurosurgeon in 1892, in an 
acromegalic patient with intracranial 
hypertension. In 1898, Baileydescribed the 
first case of pituitary adenoma associated with 
intratumoral hemorrhage. In 1906, Hoursely 
reported a series of 10 patients with pituitary 
tumors treated by temporal and subfrontal 
approaches. A milestone in the treatment of 
these tumors was marked by Schloffer, in 1907, 
when he approached sella turcica via an 
extensive lateral rhinotomy with resection of 
the septum and turbinates. In 1909, Cushing 
used a variation of Schloffler’s technique, he 
adopted sublabial incision, later described by 
Halstead and Kanavel. Brougham et al, first 
described the signs and symptoms associated 
with hemorrhage in a pituitary tumor and 
named it pituitary apoplexy; the suffix "plexi" 
comes from Greek term meaning to strike or 
to have a stroke. Another important step in the 
treatment of this pathology is the transnasal 
transfenoidal approach, first described by 
Hirsch in 1910. In 1960, Hardy used operating 
microscope in a transnasal transsphenoidal 
approach of a microadenoma. From 1990, 
endoscopeis a tool widely used in surgical 
treatment of sellar tumors. (27) 
Pituitary tumors represent about 10-15 % 
of all primary brain tumors, a much higher 
frequency, of 20-25%, is found for 
microadenomas discovered incidentally at 
autopsy. Regarding pituitary apoplexy 
clinically evident, it has a frequency of 1-2%, 
maximum 10 % in some studies of total 
pituitary tumors, the frequency is about 28 % 
if we take intoconsideration clinically silent 
pituitary apoplexy when diagnosis is 
established in histopathological examination. 
(2) (27) 
Approximately 50% of apoplectic events 
occur in patients who were not previously 
diagnosed with a pituitary tumor. The age 
range of affected patients is situated between 
first and eighth decades of life with the most 
cases in the fifth or sixth decade. Most of the 
published studies demonstrated a higher 
frequency of pituitary apoplexy among male 
compared to female population. (24) 
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Material and methods 
This paper presents a retrospective study 
over a period of five years, from January 2009 
to December 2013 and includes 98 patients 
diagnosed with pituitary apoplexy and treated 
in the Third Department of Neurosurgery, 
Emergency Clinical Hospital Bagdasar-Arseni. 
Of the 98 patients, 62 were female (63.3%) and 
36 were male (36.7%) with a ratio of female to 
male of 1.7:1. Thus, we observe a slightly 
higher frequency in female population 
compared to studies published so far. The 
patients were aged between 17 and 75 years 
old, average age being approximately 50 years, 
this aspect is in line with studies published to 
date. Follow-up period ranged from 2 months 
to 5 years. 
Clinical presentation 
The main symptom at presentation was 
sudden, intense headache, this symptom was 
encountered in 90 patients (91.83%). Other 
signs and symptoms were: vomiting showed 
by 76 patients (77.55%), decreased visual 
acuity observed in 57 patients (58.16%), visual 
field deficits in 74 patients (75.51%), cranial 
nerves palsy (III, IV, VI) observed in 14 
patients (14.28 %). None of the patients in our 
study did not show altered consciousness on 
admission (figure 1). 
 
 
Figure 1 - Clinical status at admission. 
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Figure 2 - Endocrinological status at admission. 
 
Endocrinological findings 
Endocrinological evaluation was 
performed in all patients in the study, 64 
patients had clinically nonfunctioning 
pituitary tumors (65.3%), 24 patients had 
prolactinomas (24.5%), 7 patients were known 
with GH secreting pituitary adenomas (7.1 %) 
and 3 patients had ACTH secreting pituitary 
adenomas (3.1%). Pituitary apoplexy occurs 
with no predilection to a certain category of 
pituitary adenomas. A greater frequency of 
pituitary apoplexy in the studied population 
with clinically nonfunctioning pituitary 
tumors is due to higher overall frequency of 
this type of tumor than a certain 
predisposition (figure 2). 
Imaging evaluation 
For imaging diagnosis of our patients we 
used CT scan and MRI with and without 
gadolinium; we also used this investigations to 
evaluate the postoperative status of our 
patients. 
Treatment 
In all cases included in our study, surgery 
treatment was practiced emergency. The time 
between diagnosis and surgery was of one to 
ten days. In all cases we used transnasal 
transsphenoidal approach. In cases with 
corticoid insufficiency, corticosteroid 
hormone replacement therapy was instituted. 
During surgery, and in the immediate 
postoperative period was performed 
monitoring of urine output and in patients 
with diabetes insipidus, treatment with 
desmopressin was made. 
Patient outcomes 
In the immediate postoperative period the 
best recovery was observed for cranial nerve 
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palsy (nerves III, IV and VI). As regards of 
visual function (decreased visual acuity or 
visual field deficits) recovery was partial after 
surgery. 
Of the 57 patients with impaired 
preoperative visual acuity we observed its 
improvement after surgery in 46 patients 
(80.7%), from 74 patients with visual field 
deficits at admission, postoperative 
improvement was noted in 63 patients 
(85.1%). Regarding paresis of cranial nerves 
III, IV, VI, it was almost completely recovered 
after surgery, 12 of 14 patients with severe 
preoperative paresis (85.7%). 
Our study shows that the recovery was 
better in cases where surgery was done in the 
first week after symptoms onset. This applies 
especially to recover deficits in visual acuity or 
visual field, in terms of recovery oculomotor 
nerve palsy, good results were obtained when 
surgery was made more than one week after 
the onset of the symptoms. 
Of the 98 patients included in the study, 56 
were operated during the first week after onset 
of the signs and symptoms and 42 patients 
were operated at less than a week. Of the 56 
patients operated in the first week, 54 had 
improvement of visual function (96.4%) while 
the percentage of recovery for patients 
operated more than a week is 50% (21 patients 
with improved visual function after surgery). 
Postoperative endocrinological status 
Of the 98 patients operated, all patients 
with hypopituitarism did not fully recover 
after surgery, so hormone replacement 
therapy on various axes was necessary in most 
patients. Thus in our series of patients, 60 
patients (61.2 %) required corticosteroid 
replacement therapy, 41 patients (41.8%) 
received thyroid hormone replacement, 
gonadotroph hormone replacement was 
necessary in 24 patients (25.5%) and 
desmopressin treatment in 7 patients (7.1%). 
Discussion 
Pituitary apoplexy is a clinical syndrome 
caused by the rapid expansion of a pituitary 
adenoma secondary to ischemia and /or 
intratumoral hemorrhage which causes 
compression of the cavernous sinus, chiasm 
and optic nerves. Clinical syndrome is 
characterized by brutal installed headache, 
vomiting, vertigo, meningism, deceased level 
of consciousness, ophthalmoplegia, visual 
field deficits, and decreased visual acuity. (3-5) 
All types of pituitary tumors can develop 
intratumoral apoplexy. Approximately 50% of 
apoplectic events occur in patients who had 
not been previously diagnosed with pituitary 
tumors, this leads to a delay in diagnosis. 
Wakai et al noticed in their retrospective study 
that 16.6% of their patients with pituitary 
adenomas show bleeding or intratumoral 
hematoma but only 6.8% had a clinical 
apoplectic episode. Deb and al observed 
intratumoral hemorrhage in 17.1% of patients, 
but only 5.4% had clinical signs and symptoms 
of pituitary apoplexy. (6, 7) 
The most common signs and symptoms 
present at admission were: headache (frontal 
or retroocular), visual field restriction, 
decreased visual acuity, ophthalmoplegia, 
nausea, vomiting, vertigo, meningism, 
deceased level of consciousness, facial pain or 
numbness, fever, hemiparesis, Horner 
syndrome, seizures.(8) 
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Hormonal status 
Hormonal imbalance is often found in 
pituitary apoplexy. Hypopituitarism is caused 
by increased intrasellar pressure, destruction 
of the pituitary gland by an existing adenoma 
or secondary to apoplectic event. Vedhuis and 
Hammond noted that after an episode of 
pituitary apoplexy, 88% of patients had growth 
hormone deficiency, 76% had inadequate 
secretion of luteinizing hormone, 67% had 
prolactin inappropriate secretion, 66% had 
inappropriate secretion of ACTH and 33 % 
had estradiol deficiency. (1, 26, 28)  
Diabetes insipidus is rare and occurs in 
pituitary apoplexy secondary to tumor 
compression of the infundibulum made by 
edematous or hemorrhagic material so that it 
is prevented release of antidiuretic hormone 
fromhypothalamus. Another possibility is the 
compression of the inferior hypophysial artery 
in the intracavernous portion by hemorrhagic 
material. Baha and Verrees found that diabetes 
insipidus occurs in only 2-3% of patients with 
pituitary apoplexy. (1) 
Precipitating factors 
Precipitating factors have been identified 
in about 50% of the cases diagnosed with 
pituitary apoplexy. The most common are: 
treatment with bromocriptine, estrogen 
therapy, anticoagulation, pregnancy, head 
trauma, bowel and other general surgery, 
diabetic ketoacidosis, cardiac bypass, 
radiotherapy, hypertension or hypotension, 
atherosclerosis. (1, 9, 10, 27) 
Fluctuations in blood pressure associated 
to cardiac bypassand surgical interventions 
can lead to pituitary apoplexy. Fragmentation 
of atherosclerotic plaques and engaging of 
particles within the pituitary vasculature may 
lead to gland infarction. Infections, childbirth, 
and surgery may be associated with pituitary 
apoplexy secondary to increased gland activity 
in response to increased need for stress 
hormones in these circumstances. Sneezing, 
coughing or ketoacidosis change blood flow 
and blood osmotic values precipitating 
pituitary apoplexy. (11, 12, 25)  
Numerous studies have shown a higher 
rate of hemorrhage or ischemia in pituitary 
tumors due to large discrepancy between the 
development of local circulation and tumor 
size; however small tumors can also develop 
apoplexy events. (11, 12, 25)  
Imaging studies 
CT scan has a detection rate of 21-46 % for 
pituitary apoplexy. The main detected issues 
are: hemorrhagic area, specific hyperdense, 
recent hemorrhage, mixed density when 
bleeding is associated with acute ischemic 
area. Another aspect is subarachnoid 
hemorrhage, CT scan can detect invasion of 
the basal cisterns with blood, complication 
that can accompany a series of pituitary 
apoplexy. The CT scan bone window gives us 
important information about sella turcica and 
paranasal sinuses. (3, 13) (figure 3). 
 
 
Figure 3 - Pituitary apoplexy – CT scan 
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Figure 4 - Pituitary apoplexy – MRI images 
 
MRI has a detection rate of 100 % for 
pituitary apoplexy. This imaging investigation 
has greater sensitivity and achieves better 
detection of the tissue. The issues detected in 
patients with pituitary apoplexy are specific 
heterogeneous density hemorrhage, edema 
and ischemia in the pituitary gland. (14) 
(figure 4). 
MRI is the most effective imaging 
investigation for pituitary apoplexy. Piotin et 
al wrote down that MRI imaging for this 
condition can be very varied. (15) 
Arita et al drew attention to parasellar 
dural changes. These changes are caused by 
changes in dural blood flow. He also noted 
about sphenoidal sinus mucosal thickening 
due to local venous obstruction. Another cause 
could be sphenoid sinus mucosal 
inflammation induced by inflammatory 
substances produced by tumor necrotic tissue. 
(16, 17) 
Differential diagnosis 
Differential diagnosis of pituitary apoplexy 
can be done with subarachnoid hemorrhage 
secondary to aneurysm rupture, viral or 
bacterial meningitis, spontaneous bleeding 
(hypertension, amyloidosis, metastatic or 
primary pituitary tumor), cavernous sinus 
thrombosis, carotid-cavernous fistula, 
migraine, optic neuritis, diabetic oculomotor 
palsy, temporal arthritis, vertebrobasilar 
insufficiency, transtentorial herniation. (18) 
Treatment 
The standard treatment for pituitary 
apoplexy includes high-dose of corticosteroid 
hormone which will lead to improvement of 
symptoms and surgical decompression using a 
transsphenoidal approach. Pituitary gland is 
capable to secret suitable amounts of 
hormones even when only 10% of the gland 
remains functional. (19, 20) 
The treatment of choice for pituitary 
apoplexy is represent by surgical intervention 
which also decompress cavernous sinus and 
suprasellar structures; it is recommended 
especially when there is impairment of visual 
acuity or visual field, impaired consciousness 
or when there is progression of symptoms. 
Transsphenoidal approach is safe and effective 
because it does not make a direct manipulation 
of the optic tract especially for pituitary 
apoplexy in the acute phase when there is an 
important compression of the optic pathway. 
(10, 21) 
Transcranial approaches are 
recommended when there is an important 
hemispheric hemorrhage extension, presence 
of hemorrhage and/or necrosis that extends 
beyond the intact diaphragm or when there is 
a sphenoid sinus less aerated. The main 
transcranial approaches used are pterional, 
subfrontal, and subtemporal. (22, 23, 27)  
The main complications of 
transsphenoidal surgery are: damage to the 
hypothalamus, visual tract damage, vascular 
lesions, CSF fistula, cavernous sinus injury 
(internal carotid artery, cranial nerves III, IV, 
  
 
 
 
 Romanian Neurosurgery (2015) XXIX (XXII) 1: 68 - 76          75 
 
 
 
 
 
 
 
VI), iatrogenic hypopituitarism, brainstem 
injury, and nasal complications (mucocele, 
sinusitis, fracture of hard palate or cribriform 
plate, nasal deformity). (22, 27) 
Conclusions 
Pituitary apoplexy is a disease that can 
endanger patients' lives. The clinical 
presentation may vary from minor symptoms 
to major neurological deficits and even death 
so early diagnosis and treatment are vital. 
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IRM – magnetic resonance imaging 
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